The collagen fibrils of hyaline cartilage vary in diameter depending on developmental stage and location within the tissue. In general, growth plates and fetal epiphyseal cartilages contain fibrils with diameters of less than -25 nm, whereas the permanent cartilage of adult tissues contains fibrils of -30-200 nm. The interstitial collagen fibrils of fetal cartilage are complex, having at least three collagen types as integral components. Type XI, a member of the fibrillar collagen class, has been proposed to limit fibril diameter. To test this proposition we sought to determine if Type XI collagen was preferentially associated with fibrils of smaller diameter. We focused our study on human juvenile rib growth plate, which has thin fibrils in the hypertrophic zone, thick fibrils in the resting zone or permanent cartilage, and a mixture of thin and thick fibrils in the proliferative zone. Tissues
Introduction
Although cartilage is a very complex tissue, its matrix organization can be generalized as the interaction of two systems: an inextensible network of collagen fibrils, within which is embedded a highly hydrated complex of aggregating proteoglycan (aggrecan) and hyaluronic acid. Collagen fibrils resist pulling forces, whereas the proteoglycans (PGs), forming an interfibrillar gel, resist compressive forces (Comper, 1991; Scott, 1990) . The intimate association of collagen fibrils and PG can be well appreciated in micrographs of cartilage samples prepared for electron microscopy by methods involving cryopreservation and freeze-substitution (Keene and McDonald, 1993) .
Hyaline cartilage performs two distinct functions in the vertebrate skeleton. During early development, cartilage serves as a ' Correspondence to: Nick Morris, Research Unit, Shriners Hospital for Crippled Children, 3101 SW Sam Jackson Pk. Rd., Portland, OR 97201. were examined by immunoelectron microscopy with antipeptide antibodies to the carboxyl telopeptide and to the amino terminal non-triple-helical domains of al(XI). These studies showed that (a) both epitopes of Type XI collagen were readily accessible to antibodies at the fibrillar surface, (b) Type XI collagen was associated predominantly with fibrils <25 nm in diameter, (c) Type XI collagen was not found in thick fibrils even after disruption with chaotropic agents, and (d) collagen Types II and M were associated with fibrils of all sizes. These studies were extended to human newborn epiphyseal cartilage and to fetal calfcartilage, with the same result. (1 Histochem Cytochem 43: %7-979, 1995) temporary scaffold, which is subsequently replaced by bone. Later in development and at maturity, cartilage functions as a load-bearing structure. Overlapping with both of these stages, cartilaginous growth plates provide a system for continued bone lengthening. These different functions of hyaline cartilage are reflected in the modulation of the collagen fibril structure. Embryonic cartilage is populated by thin collagen fibrils with diameters from a few to 20 or 2 5 nm (Mayne and Irwin, 1986; Muller-Glauser et al., 1986; Seegmiller et al., 1971) . This is also true for the fibrils of epiphyseal cartilage (Cameron and Robinson, 1958) , although thicker fibrils are also observed , and for the fibrils of the hypertrophic zone of the growth plate (Poole et al., 1989) . The fact that these tissues are designed for transition and replacement in addition to load bearing and support provides a rationale for the predominance of thin fibrils (Poole et al., 1989) . Mature articular cartilage usually contains thicker fibrils, nm in diameter (Lane and Weiss, 1975) . and the average diameter varies with location from the superficial to the deeper zones (Lane and Weiss, 1975; Muir et al., 1970) . Within mature cartilage, the matrix immediately surrounding the chondrocyte is composed largely of thin fibrils, 15-25 nm in diameter (Poole et al., 1985) . 967
These observations indicate that regulation of fibril diameter is an important aspect of cartilage function, a conclusion supported by the pathology of human and animal models of chondrodysplasia. In the epiphyseal cartilage of the chondrodystrophic (cho) mouse (Seegmiller et al., 1971 ) and in transgenic mice overproducing Type I1 collagen (Garofalo et al., 1993) , an abundance of abnormally large fibrils is observed. Abnormalities of collagen fibril diameter are also observed in some human chondrodysplasias (Horton and Hecht, 1993) . These alterations of normal fibril diameter may contribute directly to failure of the tissue. The mechanism by which interstitial collagen fibril diameter is controlled is uncertain, but it is tempting to hypothesize that components of the fibrils themselves are responsible (Linsenmayer et al., 1993; Eikenberry et al., 1992) .
If this hypothesis is correct, Type XI collagen molecules, particularly those retaining the amino terminal domain, should be associated with fibrils of smaller diameter. We have examined juvenile rib growth plate cartilage by immunoelectron microscopy, since this tissue contains collagen fibrils with a wide range of diameters. We have prepared antibodies to the amino terminal domain of al(xI) to specifically localize this domain. We have also prepared antibodies to the carboxyl telopeptide, since this domain is adjacent to the triple helix and is not subject to proteolytic processing. Our results demonstrate that antibodies to both domains readily label fibrils whose diameters are <25 nm. Similar observations were made in fetal bovine and newborn human epiphyseal cartilage.
Fetal cartilage collagen fibrils contain three integral, covalently associated collagens (Mendler et al., 1989) . Type I1 collagen constitutes the bulk of the cartilage interstitial fibril and is a member of the fibrillar collagen family characterized by a 300-nm uninterlagen, a member of the FACIT C~. S S of collagens (van der Rest et 
Materials and Metho&
Preparation of Antibodies. Peptides coding for the rat al(X1) carboxy telopeptide domain, IQPLPIIsPKKmHTEsIQA et 1988) (used make antibody mti-XI-telo), and a sequence within the human rez, 1990) (used to make antibody anti-XI-amino). were synthesized on ruPted triple-helical domain (Miller and Gay, 1987) . Type I x Colamino terminal domain, SSAPKAAQAQEPQIDEYA (Yoshioka and Ramial., 1991; Olsen, 1989) , has been localized to the surface of fibrils sheared from embryonic chick sternal cartilage and human epiphyseal cartilage by homogenization Vaughan et al., 1988) . However, localization by immunoelectron microscopy of intact tissue has suggested that Type IX is more restricted to the intersection of fibrils (Muller-Glauser et al., 1986) . Application of this method to adult articular cartilage has indicated a preferential association of Type IX collagen with the thin fibrils of the chondron and pericellular matrix (Wotton et al., 1988) . Type XI collagen, a fibrillar collagen found prevalently in cartilage, is a heterotrimeric molecule containing two unique gene products, al(X1) and a2(XI) (Burgeson et al., 1980; Burgeson and Hollister, 1979) . and a third chain, a3(XI), which appears to be identical to al(I1) (Oxford et al., 1994; Furuto and Miller, 1983) . Type XI collagen has been localized to the interior of embryonic chick and fetal bovine cartilage fibrils (Mendler et al. 1989; Petit et al., 1993) .
The al(X1) and a2(XI) chains contain homologous amino terminal domains much larger than, and unrelated to, that of Type I1 collagen (Zhidkova et al., 1993; Neame et al., 1990; Yoshioka and Ramirez, 1990 ) and more closely resembling the FACIT collagens (Walchli et al., 1993) . Unlike Type I1 and most other fibrillar collagen chains, a portion of this amino terminal domain, including the minor triple helix, is retained after proteolytic processing (Thom and Morris, 1991; Morris and Bachinger, 1987) . The rate of proteolytic processing of the al(X1) chain is inordinately slow (Thom and Morris, 1991) , making it likely that the intact domain is incorporated into the fibrils as part of a Type XI molecule. It is very unlikely that the interior of the cartilage collagen fibril could accommodate the large amino terminal domain of Type XI collagen, since retention of the much smaller amino propeptide of Type I collagen leads to the disruption of dermal collagen fibrils observed in dermatosporaxis (Piirard et al., 1986) and in Ehlers-Danlos syndrome Type VI1 (Holmes et al., 1993) . If proteolytic processing of Type XI collagen occurs in the fibril, then the amino terminal domain must be exposed on the surface of the fibril, thus limiting additional deposition of Type I1 collagen. Together, these observations make Type XI collagen a likely candidate participant in the regulation of fibril diameter (Thom and Morris, 1991) . a Milligen 9050 peptide synthesizer. Peptides were purified by HPLC (Waters) on a vydac C-18 reverse-phase column and confirmed by sequencing. Peptide synthesis and sequencing were provided by Jay Gambee of the Shriners Hospital analytical core facility. Coupling of peptide to keyhole limpet hemocyanin was previously described (Reichlin, 1980) , and immunization of New Zealand White rabbits was performed according to the protocol of Harlow and Lane (1988) . Antisera were titered against peptide by ELISA. Antiserum anti-XI-telo recognizes the carboxyl telopeptide of Type XI collagen and was previously characterized by indirect immunofluorescent staining of cartilage. Western blotting, and immunoprecipitation (Oxford et al., 1994) . Antibody to the amino terminal domain, anti-XI-amino, is described in the Results.
Antiserum anti-IX, directed against bovine Type IX collagen was raised in New Zealand White rabbits against the pepsin-generated fragment of Type IX containing the COL2 and COL3 domains (the fragment termed HMW Mayne and Irwin, 1986 ) purified from the digestion as an SDS-PAGE gel band (Granger and Lazarides, 1979) . The antiserum was characterized by Western blotting and recognized Type IX collagen but not collagen Type I1 or XI. Antibody anti-11, produced in goat to bovine Type I1 collagen and purified by affinity chromatography was obtained from Southern Biotechnology Associates (Birmingham, AL; cat #1320-01).
Tissue. Human rib cartilage from individuals aged 11-15 years was obtained as a byproduct of surgical procedures performed to correct scoliotic spinal curvature. The growth plate was exposed and separated from the bony posterior portion of the rib by a primary fracture. Femoral head cartilage was obtained from a newborn infant that had expired due to internal organ failure. Fetal bovine cartilage was obtained from the femoral head and condyles of second-trimester (16 inches from crown to rump) fetal calves. From all three tissue sources, perichondrium and adhering tissues were removed and the growth plates were retained Immunofluorescence. Indirect immunofluorescence staining was performed as previously described (Sakai et al., 1986) .
Electron Microscopy. The growth plate of human rib was selected for these studies primarily because of its small size, measuring less than 1 mm from the zone of calcification to the beginning of the resting zone. Therefore, after immunolocalization procedures, the entire growth plate could be included within one section and viewed without interruption in the electron microscope on a 1 x 2-mm slotted grid. En bloc (diffusion) procedures used to expose the tissues to primary and secondary antibody conjugates, to wash away unbound antibody, and to fix, dehydrate, and embed ULTRASTRUCTURAL LOCALIZATION OF COLLAGEN TYPES II, IX, AND XI the samples in preparation for electron microscopy were carried out using a previously described protocol (Sakai et al., 1986) . Briefly, to partially disrupt the matrix of PGs, which would otherwise inhibit the penetration of antibody, tissues were exposed overnight at 4°C to chondroitinase ABC (Sigma; St Louis, MO) 290 U/ml in PBS. Samples targeted for immunolocalization of Type IX collagen were treated after chondroitinase with 1 M guanidine HC1 (Amresco; Solon, OH) for 60 min at room temperature. After rinsing, tissues were immersed in primary antibody (diluted 1:5), washed, then immersed in secondary antibody conjugated to 5-nm gold (Amersham; Arlington Heights, 1L) diluted 1:3 in BSA buffer. Samples were then washed, fuced in aldehyde containing 0.1% tannic acid, postfixed in 0~0 4 , and embedded in Spurr's epoxy. In experiments designed to expose the interior of fibrils to antibody, tissues were incubated in 6 M guanidine HCI overnight at 4°C before antibody labeling. Tissue homogenates were prepared from slices of tissue taken parallel to the growth plate, which included the calcification, hypertrophic, proliferative, and resting zones. To directly expose all fibrils within the tissue to antibody, small cartilage samples were homogenized in 0.2 M ammonium bicarbonate buffer on ice using a polytron tissue homogenizer (Brinkman Instruments; Westbury, NY) until no visible tissue fragments remained. Homogenates were then immunolabeled in suspension as described previously (Keene et al., 1991) .
Measurement of Labeled Fibrils. After immunolabeling procedures, Type XI collagen was considered to be a component of a fibril only if the fibril was clearly individual and labeled with gold at three independent sites. Measurements were made on prints at final magnifications of x 150,000 using a x 10 scale loupe (Polaron; Cambridge. MA).
Results

Morphology of the Rib Growth Plate
The growth plate of human juvenile rib is very narrow and even. The zone of calcification and the hypertrophic, proliferative, and resting zones were contained within less than 1 mm. There was a gradient in fibril diameters from the calcified to the resting zone ( Figure 1 ). In the zone of provisional calcification and in the hypertrophic zone, the collagen fibrils were consistently thin (less than 20 nm) and unbanded. The fibrils were not well organized except within the longitudinal septa, where large bundles of collagen fibrils ran through the septa perpendicular to the growth plate axis. Within the proliferative zone, calcium crystals was absent and the collagen bundles appeared more organized in the longitudinal septa. At the end of the proliferative zone, thicker, banded, fibrils were observed along with thin, unbanded fibrils. The ratio of large to small diameter fibrils steadily increased until well within the resting zone, where large banded fibrils of 50-100 nm predominated and thin fibrils were rare. The morphology of the resting zone of rib cartilage resembled that of mature articular cartilage and was additionally typified by a paucity of cells.
Characterization of .Spec+c Antisera for Type XI Collagen
Previous localization of type XI collagen utilized antibodies to the triple helical domain (Petit et al., 1993; Mendler et al., 1989) , but these epitopes proved to be masked. The immunolocalization studies described herein utilized two different anti-peptide antisera. Because the amino terminal domain of Type XI is a putative func-tional element in the regulation of fibril diameter, an anti-peptide antibody, anti-XI-amino, directed against this region was prepared. Specifically, anti-XI-amino recognizes a sequence in the middle of the non-triple-helical region of the al(XI) amino terminal domain (see Materials and Methods). The specificity of anti-XI-amino and its ability to recognize native protein were tested by immunoprecipitation of Type XI collagen from a mixture of 3H-proline-labeled proteins synthesized by rat chondrosarcoma tissue in culture (Figure 2) . When analyzed by SDS-PAGE, the immunoprecipitated bands (Lane 3) corresponded to various proteolytically processed forms of Type XI collagen (Thom and Morris, 1991) . After digestion of the immunoprecipitate with pepsin, the three bands characteristic of Type XI collagen were observed (Lane 5). By immunoblotting (Lane I), the antibody recognized predominantly a band corresponding to pNa1 (XI), which contains an intact amino terminal domain. No evidence of recognition of Type 11, other collagens, or other proteins was detected by this analysis.
A previously characterized antiserum, anti-XI-telo, recognizing the 21 amino-acid carboxyl telopeptide of al(XI), a domain adjacent to the triple helix, was used to identify any form of Type XI collagen regardless of the extent of proteolytic processing. Although only results with anti-XI-telo are shown, identical results were achieved with a second antiserum to the carboxyl telopeptide. The peptide antigen for this antibody lacked the amino terminal six amino acids, the portion of the sequence shared by pro-al(V) (Li et al., 1995) .
Localization of Types 11, IX, and XI Collagen by Immunohistochemistry
Both type XI collagen-specific antibodies were used to localize Type XI collagen in human rib growth plate by indirect immunofluorescent staining. The results for the anti-XI-amino, directed against the amino terminal domain of pro-a1 (XI), are shown in Figure  3A and 3B. Each Type XI-specific antibody stained the cartilaginous matrix of the hypertrophic and proliferative zones. The staining was not uniform in these areas, tending to be more intense within rather than between baskets of cells. Nevertheless, some staining was observed in longitudinal septa, particularly in the lower hypertrophic and calcified zones. Staining was also observed in a very restricted pericellular pattern in the resting zone. Positive immunolabeling required only that the sections be exposed to chondroitinase, indicating that these Type XI collagen epitopes are not otherwise masked. Staining intensity diminished dramatically in the upper proliferative zone and in the resting cartilage was restricted exclusively to the periphery of cells. Antibodies to type I1 collagen stained all zones of cartilage ( Figures 3C and 3D) , although the denser resting cartilage sometimes did not stain as well. Antibodies to Type IX collagen also directed generalizing staining of all zones of cartilage (data not shown).
lmmunoelectron Microscopy of Human Rib Growth Plate
The distribution of Type XI collagen was determined by en bloc immunoelectron microscopy of tissue samples treated with chondroitinase. Both the C-telopeptide antibody (anti-XI-telo) and the 970 KEENE, OXFORD, MORRIS ~~~ ULTRASTRUC'IWRAL LOCALIZATION OF COLLAGEN TYPES 11. IX. AND XI 97 1 amino terminal antibody (anti-XI-amino) preferentially labeled thin fibrils with diameters of <20 nm. Because these fibrils are most concentrated in the hypertrophic and proliferative zones of the growth plate, these regions were most intensely labeled ( Figures  4A and 4B) . The frequency of labeled fibrils decreased to zero in areas progressively closer to the resting zone (Figures 5A and 5B; see also Figures 6A and 6C) . This correlates well with the distribution of Type XI as identified by immunofluorescence and with the lack of thin fibrils as identified by electron microscopy. Antibodydirected gold labeling occasionally demonstrated a 54-nm periodicity typical of fibrillar collagens prepared for electron microscopy. Antibodies specific for Type I1 and IX collagens labeled fibrils of all diameters within the entire growth plate ( Figures 4C, 4D . 5C. 5D. and 6E), including thin fibrils.
Regions of cartilage that contained increasing numbers of thick fibrils also showed an increase in the packing density of collagen fibrils. Inspection of Figure 1 shows that there is less interfibrillar space in the upper proliferative and resting zones, where the concentration of thick fibrils is greatest. Blocks of tissue from these zones tended to be much more resistant to the penetration of antibody. even after chondroitinase treatment. To rule out the lack of substantial antibody penetration into the tissue as the basis for labeling only thin fibrils, the cartilage was briefly homogenized to generate sheared fibrils and the homogenate was labeled in suspension. All fibrils within the area sampled therefore had equal access to antibody. The immunolabeled suspension was then pelleted, fixed, and embedded for electron microscopy (see Materials and Methods). As in whole tissue samples, only thin fibrils were labeled by either anti-XI-telo or anti-XI-amino ( Figures SE and 5F .
The failure of thick fibrils in any location to be labeled with antibodies to the non-triple-helical domains of Type XI collagen could be explained by two mechanisms. It is possible that these epitopes of Type XI collagen molecules at or near the surface, or in the interior of thicker fibrils, are masked by overlying layers of Type I1 collagen, Type IX collagen, and other fibril-associated components. Alternatively, it may be that thicker fibrils simply lack Type XI collagen altogether. If Type XI collagen antibody epitopes are masked in thicker fibrils, then disruption of the fibril should expose them. Consequently, blocks of cartilage were extensively treated with guanidine after incubation in chondroitinase, then immunolabeled with anti-XI-telo, anti-XI-amino, or anti-I1 collagen antibodies (Figures 6B, 6D, and 6F) . Treatment with guanidine significantly disrupted the fibrils (compare Figures 6A, 6C , and BE with Figures 6B. 6D, and 6F ). Occasionally, a thick guanidine-treated fibril remained relatively intact ( Figure 6D ). No labeling of disrupted thick fibrils could be detected with either antibody to Type XI collagen after guanidine treatment ( Figures  6B and 6D) . However, the identical procedure using antibody specific for collagen Type I1 ( Figure 6F and secondary gold conjugate into the interior of the fibril (arrow, Figure 6F ). although the exterior of the fibrils was still more heavily labeled because these regions were directly exposed to the antibodies. Similar experiments designed to swell or partially disrupt fibrils with acetic acid, urea, and bacterial collagenase gave similar results (not shown).
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Analysis of Other Tissues
To determine if the localization of Type XI collagen only to thin fibrils might be peculiar to the growth plate of adolescent rib, similar immunolocalization experiments were performed with fetal bovine epiphyseal cartilage and newborn human epiphyseal cartilage. Early fetal cartilage contains fibrils ofsmall diameter throughout the entire matrix. Both anti-XI-amino and anti-XI-telo readily labeled these fibrils (Figures 7C and 7D) . The fibril morphology of human newborn epiphyseal cartilage was intermediate between fetal bovine epiphyseal cartilage and juvenile rib cartilage. Thin fibrils were abundant in all areas of the cartilage, but some thicker banded fibrils appeared in the upper proliferative and resting zones. Antibody recognizing Type XI collagen consistently labeled only thin fibrils, leaving thick fibrils unlabeled ( Figures 7A and 7B) .
Analysis of the Diameter of Fibrils Labeling with Antibodies to Type X I Collagen
In the micrographs presented above, the fibrils that labeled with antibodies to Type XI collagen were usually <20 nm in diameter. This perception was documented by measurement of the diameter of labeled fibrils. These data are presented in Figure 8 . In human cartilage, including newborn epiphyseal cartilage and covering all zones of the growth plate, labeled fibrils had a mean diameter of 13.5 t 4.3 nm and a range of -5-25 nm. even though unlabeled fibrils as large as 110 nm in diameter were found in these tissues. In the feral bovine epiphyseal cartilage, the labeled fibrils had a mean diameter of 15.7 f 3.3 nm, and labeled fibrils of <I5 nm were under-represented in comparison with human cartilage. Labeling of fibrils >25 nm in diameter was very rare in either case.
Discussion
The most significant finding of this study was the association of Type XI collagen with only the thin fibrils of cartilage, those less than ~2 5 nm in diamerer. The diameters of labeled fibrils averaged 13.5 nm in bovine tissues and 15.7 in human tissues. Antibody labeling did not require swelling or other disruption of the fibril; hence. these epitopes appear to be directly accessible to antibody at the surface of the fibril. Selective labeling of thin fibrils did not result from the removal of the epitope by proteolytic processing on thicker fibrils, since antibody to the carboxyl telopeptide, which is not further processed in the matrix, also labeled only these thin fibrils. Disruption of the fibrils with various concentrations of guanidine did not unmask cryptic epitopes of Type XI collagen from either the exterior or the interior of thicker fibrils but also did not interfere with the labeling of thin fibrils. However, the pre-embedding technique employed does not permit one to conclude that Type XI collagen is completely absent from the large fibrils. Rather, this ultrastructural analysis suggests that there are two populations of fibrils, those that contain a significant portion . . Figure 5 . lmmunoelectron microscopy of the upper proliferative zone of human juvenile rib shows that distribution of Type XI is restricted to thin collagen fibrils. (A) Anti-XI-telo; (E) anti-XI-amino. Antibodies to collage Type II (C) and Type IX (D) localize to all fibrils, thick or thin. To gain better access to the tissues, cartilage samples were sheared and the resulting fibrils labeled in suspension (materials and methods) with anti-XI-telo (E) and anti-XI-amino (F). Bar = 200 nm. of Type XI collagen and are thin, and those that do not contain significant amounts of Type XI collagen and are thick.
In addition to fetal cartilage, thin fibrils predominated in the hypertrophic and lower proliferative zones of juvenile growth plate cartilage (Figure 1) . The resting zone of cartilage contained primarily thick fibrils. The ultrastructural correlation of Type XI collagen with thin fibrils is consistent with biochemical analysis of juvenile porcine cartilage showing that the growth plate is enriched in Type XI collagen relative to resting cartilage (Wardale and Duance, 1993) and with biosynthetic data in rabbits demonstrating that after the newborn period, Type XI collagen is preferentially synthesized in the growth plate (Sussman et al., 1984) . The immunofluorescence staining in the resting zone with antibodies to Type XI collagen (Figure 3) is likely due to the presence of Type XI collagen in the thin fibrils of the pericellular matrix (Poole et al., 1985 (Poole et al., , 1992 .
In previous studies, polyclonal antibodies directed against the triple-helical domain of Type XI collagen failed to label thin (15-20nm diameter) intact epiphyseal cartilage collagen fibrils but did label cut ends or otherwise disrupted fibrils, suggesting that the triple helix was sequestered within the interior of the fibril (Petit et al., 1993; Mendler et al., 1989) . In the present study, domains at either end of the triple helix within intact fibrils were readily accessible to antibody. A similar paradox for Type V collagen in the heterotypic Type IlType V fibrils of cornea was explained by the proposition that the triple helix of Type V lay beneath the surface parallel to the fibril axis, whereas the large amino terminal domain at the end of the minor helix protruded via a flexible hinge through a gap region in the Type I collagen packing array (Linsenmayer et al., 1993) . The flexible hinge region identified in fibrillar collagens between the major and minor triple helices of fibrillar collagens (Hofmann et al., 1984) also exists in Type XI collagen (Morris and Bachinger, 1987) . Because the Type XI-containing cartilage fibrils are very thin, smaller in diameter than the corneal fibrils, and because the carboxyl telopeptide is also positioned at the gap region of the fibril, this epitope may be more accessible from the fibril surface. Such a possibility might be enhanced if the lower thermal stability of the tripie-helical domains of Type XI collagen resulted in a greater flexibility of the molecule (Morris et al., 1990) .
Few studies have addressed the specific localization of Type IX collagen by immunoelectron microscopy. In contrast to the results of these previous studies, we demonstrated that both the thick fibrils (>loo nm) within resting or permanent cartilage, as well as the thin fibrils of the growth plate, were labeled. The labeling was extensive on the surface of both populations of fibrils, reminiscent of the distribution of Type IX on isolated fibrils Vaughan et al., 1988) and contrasting with the more restricted distribution observed previously in intact chick embryo sternal cartilage (Muller-Glauser et al., 1986) . This may be due to the age and the specific tissue used in these studies as well as to our use of 1 M guanidine before labeling. Examination of mature porcine articular cartilage by Wotton et al. (1988) revealed only sparse labeling of thick fibrils and more intense labeling of the fine fibrils of the chondron. The more intense labeling of thick fibrils of the resting zone observed in our study could result from the use of conditions that maximize the penetration of this very dense connective tissue by primary and secondary antibodies. These conditions include long incubation times, small gold particle size, and the use of the 1 M guanidine wash before labeling.
The distribution of Types IX and XI underscores differing aspects of their functions. The extensive labeling of mature cartilage collagen fibrils of all diameters seen here is consistent with the requirement for Type IX collagen in the maintenance of tissue integrity. Abolition of Type IX collagen via an al(IX) gene knockout in mice (Fassler et al., 1994) results in normal tissue development and collagen fibril structure, but also in the adult onset of severe osteoarthritis. The low abundance, the location within the fibril, and the large amino terminal domains that are slowly and incompletely processed all suggest that one function of Type XI collagen is to regulate fibril diameter. In support of this notion, abolition of Type XI collagen accumulation in the cartilage matrix that occurs as a result of the recessive (chokho) mouse mutation (Li et al., 1995) leads to severe chondrodystrophy (Seegmiller et al., 1971) . The cartilage of the mutant mouse contains abnormally large collagen fibrils and shows loss of biomechanical rigidity. It is also interesting that ULTRASTRUCTURAL LOCALIZATION OF COLLAGEN TYPES 11, M, AND XI overexpression of a normal Type 11 collagen transgene led to t h e appearance of a subpopulation of abnormally large fibrils (Garafalo e t al., 1993) which, at t h e highest levels of expression, was pathogenic. The loss of the regulation of fibril diameter in this case may be d u e to t h e alteration in the ratio of collagen Types I1 a n d XI.
The mechanism by which type XI collagen may perform this regulatory function remains unknown. T h e large amino terminal domains are likely to be important elements of t h e function. In this regard, t h e recent observation of a complex pattern of alternative exon usage in t h e al(X1) a n d a2(XI) amino terminal domains (Oxford e t al., 1995; Tsumaki a n d Kimura, 1995; Zhidkova e t al., 1995) may be important. The extreme fragility of t h e cartilage in t h e c h o k h o mouse may also reflect t h e loss of interactions between the collagen fibrils a n d other matrix components, which could be mediated by t h e large amino terminal domain of al(X1) found at the fibril surface. Early in development all of the cartilage, collagen fibrils are thin and relatively uniform in diameter. Although some thin fibrils persist in discrete regions of mature cartilage, most of t h e cartilage matrix is composed of thicker fibrils. How larger fibrils arise and what role Type XI collagen has in this process merits further investigation.
